Development and validation of a nomogram to predict cancer-specific survival in middle-aged patients with papillary thyroid cancer: A SEER database study
2023 · Heliyon · 14 citations
https://doi.org/10.1016/j.heliyon.2023.e13665
C
Chenghao Zhanghuang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
524
Citations
13
h-index
20
i10-index
Chenghao Zhanghuang is an academic researcher from Kunming Medical University. The author has contributed to research in topics: Renal and related cancers & Renal cell carcinoma treatment & Bladder and Urothelial Cancer Treatments. The author has an h-index of 13, co-authored 58 publications.
ORCID: 0000-0001-6421-767XPapers by this author
worksDevelopment and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study
2022 · Frontiers in Public Health · 13 citations
https://doi.org/10.3389/fpubh.2022.840525
Enhancing clinical decision-making: A novel nomogram for stratifying cancer-specific survival in middle-aged individuals with follicular thyroid carcinoma utilizing SEER data
2024 · Heliyon · 7 citations
https://doi.org/10.1016/j.heliyon.2024.e31876
Clinical and prognostic analysis of 42 children with malignant rhabdoid tumor of the kidney: a 7-year retrospective multi-center study
2022 · BMC Pediatrics · 6 citations
https://doi.org/10.1186/s12887-022-03643-1
Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer
2023 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-023-44911-z
The PI3K-AKT-mTOR signaling pathway mediates the cytoskeletal remodeling and epithelial-mesenchymal transition in bladder outlet obstruction
2023 · Heliyon · 6 citations
https://doi.org/10.1016/j.heliyon.2023.e21281
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat